Total Payments
$22,983
2024 Payments
$1,319
Companies
31
Transactions
559
Medicare Patients
2,593
Medicare Billing
$272,314
Payment Breakdown by Category
Food & Beverage$12,966 (56.4%)
Consulting$4,500 (19.6%)
Other$3,863 (16.8%)
Travel$1,167 (5.1%)
Education$487.17 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,966 | 536 | 56.4% |
| Consulting Fee | $4,500 | 2 | 19.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,863 | 5 | 16.8% |
| Travel and Lodging | $1,167 | 4 | 5.1% |
| Education | $487.17 | 12 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $5,178 | 26 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,142 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,458 | 174 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,418 | 79 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,283 | 24 | $0 (2019) |
| Genentech USA, Inc. | $1,500 | 52 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $918.86 | 52 | $0 (2024) |
| Philips Electronics North America Corporation | $618.96 | 9 | $0 (2021) |
| GENZYME CORPORATION | $576.74 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $263.26 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,319 | 58 | AstraZeneca Pharmaceuticals LP ($519.96) |
| 2023 | $1,309 | 52 | GlaxoSmithKline, LLC. ($447.28) |
| 2022 | $1,360 | 52 | GENZYME CORPORATION ($340.02) |
| 2021 | $853.39 | 48 | GlaxoSmithKline, LLC. ($259.10) |
| 2020 | $683.25 | 29 | GlaxoSmithKline, LLC. ($229.38) |
| 2019 | $6,924 | 107 | Insmed, Inc. ($4,792) |
| 2018 | $2,736 | 103 | AstraZeneca Pharmaceuticals LP ($537.55) |
| 2017 | $7,799 | 110 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,252) |
All Payment Transactions
559 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $65.79 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: Respiratory | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.26 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Immunology | ||||||
| 07/24/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Sleep | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 661 | 937 | $243,437 | $71,435 |
| 2022 | 13 | 557 | 758 | $207,508 | $62,568 |
| 2021 | 14 | 657 | 876 | $229,334 | $76,654 |
| 2020 | 13 | 718 | 915 | $155,320 | $61,657 |
Total Patients
2,593
Total Services
3,486
Medicare Billing
$272,314
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 338 | $93,973 | $31,789 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $25,017 | $8,568 | 34.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 11 | 11 | $29,304 | $6,346 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 40 | $15,440 | $5,834 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 95 | $18,715 | $5,801 | 31.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 64 | 65 | $28,730 | $5,097 | 17.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 24 | $9,912 | $3,415 | 34.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 23 | $3,427 | $1,493 | 43.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 62 | 69 | $3,795 | $1,202 | 31.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 70 | $2,590 | $809.82 | 31.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 38 | 41 | $3,362 | $383.61 | 11.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 39 | 42 | $4,704 | $338.80 | 7.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 38 | 41 | $3,731 | $283.94 | 7.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 11 | 11 | $737.00 | $73.37 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 283 | $78,674 | $26,480 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 118 | $23,246 | $7,478 | 32.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 11 | 12 | $16,700 | $6,601 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $14,994 | $5,346 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 35 | $13,510 | $4,875 | 36.1% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 54 | 55 | $27,944 | $4,312 | 15.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 22 | $9,086 | $3,546 | 39.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 27 | $4,023 | $1,564 | 38.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 43 | 51 | $2,805 | $824.29 | 29.4% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 11 | 12 | $6,888 | $777.12 | 11.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 29 | 32 | $2,624 | $284.61 | 10.8% |
About Dr. Tad Jackson, MD
Dr. Tad Jackson, MD is a Pulmonary Disease healthcare provider based in Lihue, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497722151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tad Jackson, MD has received a total of $22,983 in payments from pharmaceutical and medical device companies, with $1,319 received in 2024. These payments were reported across 559 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($12,966).
As a Medicare-enrolled provider, Jackson has provided services to 2,593 Medicare beneficiaries, totaling 3,486 services with total Medicare billing of $272,314. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Lihue, HI
- Active Since 03/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1497722151
Products in Payments
- Arikayce (Drug) $1,738
- DUPIXENT (Biological) $1,540
- NUCALA (Biological) $1,163
- FEVIPIPRANT (Drug) $1,010
- TRELEGY ELLIPTA (Drug) $778.31
- Esbriet (Biological) $630.43
- TEZSPIRE (Biological) $437.20
- Xolair (Biological) $419.66
- OFEV (Drug) $404.22
- FASENRA (Drug) $377.90
- ENTRESTO (Drug) $355.57
- BREZTRI (Drug) $327.30
- SYMBICORT (Drug) $283.31
- SPIRIVA RESPIMAT (Drug) $265.34
- Letairis (Drug) $250.00
- PRI Cpap Auto (Device) $218.00
- STIOLTO RESPIMAT (Drug) $199.72
- FASENRA (Biological) $183.30
- BREO (Drug) $178.68
- ANORO (Drug) $166.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.